Skip to main content
Clinical Trials/NL-OMON50331
NL-OMON50331
Not yet recruiting
Not Applicable

Right ventricular contractile reserve and oxygen consumption in pulmonary arterial hypertension - RV contractile reserve and oxygen consumption in PAH

Vrije Universiteit Medisch Centrum0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary arterial hypertension
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
15
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • Age \>18 years
  • Patients have to be diagnosed with idiopathic \-, hereditary \-, or drug\- and
  • toxins induced PAH or chronic thrombo\-embolic pulmonary hypertension (CTEPH)
  • conform ESC/ERS guidelines. PAH is diagnosed when the following criteria are
  • o Mean Pulmonary Artery Pressure (mPAP) \>\= 25 mmHg
  • o Pulmonary Arterial Wedge Pressure (PAWP) \> 15 mmHg
  • o Other possible causes of PAH are excluded

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • \<1 year since last participation in research that included nuclear imaging
  • Congenital heart disease
  • Left sided heart disease
  • Pulmonary Hypertension other than idiopathic \-, hereditary \-, or drug\- and
  • toxins induced PAH or CTEPH
  • Known coronary artery disease
  • Pregnancy
  • Malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials